SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-21-098576
Filing Date
2021-08-02
Accepted
2021-08-02 08:23:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2123817d1_sc13da.htm SC 13D/A 31277
  Complete submission text file 0001104659-21-098576.txt   32940
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Filed by) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Subject) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-91006 | Film No.: 211134835
SIC: 2836 Biological Products, (No Diagnostic Substances)